We previously generated a conditional CM knock-in (Cbfb56M/+/Mx1-Cre) mouse model32,33, which recapitulates human inv(16) AML development in an average of 3–4 months after induction of CM expression by poly(I:C) treatment. The gene discussed is MX1; the disease is acute myeloid leukemia.